Country Overviews

... significantly affectdrugmaker revenues, threatening Spain’s attractiveness as a location in which to sell drugs, especially aspublic health spending accounts for 71% of total health expenditure. Headline Expenditure Projections .. Pharmaceuticals: EUR14.65bn (US$20.51bn) in 2011 to ...  |  more...

... a result of the increased prevalence of chronic disease with age, thereforeconsuming a disproportionately large share of healthcare services. Such robust demand for services overthe coming years means the government will need to adapt strategies ...  |  more...

... maintain it is highly unlikely the Canadian governmentwill introduce punitive price controls like those witnessed across Europe. Instead, the country’shealthcare market will continue to place downward pressures on pharmaceutical prices as policiesmandating generic substitution compress ...  |  more...

... of individual funding for medicines, given the high out-of-pocketcontribution to healthcare. Nevertheless, volume demand will continue to grow on the back of demographic andepidemiological changes, supported by the expansion of modernisation of healthcare provision in ...  |  more...

... the pharmaceutical market will achieve elevated growth over thenext five years and this view has been reinforced by the latest available trade data. However, the countryeconomic growth path is dependent on the stability of the ...  |  more...

... has been able to support it by subsidising sick funds tomake a wider range of treatments available. In particular the introduction of some expensive biologicaldrugs into the re-imbursement basket will present opportunities for multinational drugmakers. ...  |  more...

... multinationaldrugmakers via a reduction in the number of counterfeit and substandard drugs and the enlargement ofthe legitimate pharmaceutical market. However, we highlight Lebanon's close ties with Syria as a risk.Instability in the region, combined with ...  |  more...

... With the most recent Sudanese civil war ended in 2005 after more than 20 years offighting, tension remains high and violent clashes between forces in South Sudan and its northernneighbour continue. It is clear that ...  |  more...

... in January – but were nevertheless expected to bereconsidered – are now less likely progress. The new claw-back tax, which has been in effect sinceOctober 2011 and was modified in November, is expected to remain ...  |  more...

... has also increased the allocation for social security and welfare by 74% y-o-y to OMR385mn (US$1.01bn). Expenditure on the health sector is an estimated OMR500mn (US$1.32bn), which is five percent of total public expenditure. Furthermore, ...  |  more...

... force for behind this expansion. We expect the gradually improving intellectual property (IP) regulatory framework and increasing medical coverage among the population to increase the country’s attractiveness to the multinational pharmaceutical companies. Headline Expenditure Projections ...  |  more...

... to continue in the medium term, cost-containment measures will increasingly prioritise the use of generic drugs in the public sector. We also note that the anticipation of a year of the dragon baby boom can ...  |  more...